Endotronix snags $32 mln Series C

Woodridge, Illinois-based Endotronix Inc, which provides "innovative" solutions to patients with advanced heart failure, has raised $32 million in Series C financing. The investors included BioVentures Investors, SV Life Sciences, Lumira Capital, Aperture Venture Partners and OSF Ventures.

14 July 2016•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail